Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics Indian Medical PG Practice Questions and MCQs

Question 341: Which drug exhibits zero-order kinetics?

A. Digoxin
B. Theophylline (Correct Answer)
C. Phenobarbitone
D. Etomidate

Explanation: ### Explanation **Concept: Zero-Order vs. First-Order Kinetics** Most drugs follow **first-order kinetics**, where a constant *fraction* of the drug is eliminated per unit time (rate depends on plasma concentration). In contrast, **zero-order kinetics** occurs when the elimination mechanisms (enzymes/transporters) become saturated. Here, a constant *amount* of the drug is eliminated per unit time, regardless of concentration. **Why Theophylline is Correct:** Theophylline is a classic example of a drug that exhibits **saturable (capacity-limited) kinetics**. At therapeutic or high concentrations, its metabolic pathways in the liver become saturated, shifting its elimination from first-order to zero-order. This is clinically significant because small dose increases can lead to disproportionately large increases in plasma levels, risking toxicity. **Analysis of Incorrect Options:** * **Digoxin (A):** Follows first-order kinetics. It has a large volume of distribution and is primarily excreted unchanged by the kidneys. * **Phenobarbitone (C):** While some barbiturates have complex metabolism, Phenobarbitone generally follows first-order kinetics. (Note: Phenytoin is the barbiturate-like anticonvulsant famous for zero-order kinetics). * **Etomidate (D):** An intravenous anesthetic agent that follows first-order kinetics with a rapid redistribution phase. **High-Yield Clinical Pearls for NEET-PG:** To remember drugs following Zero-Order Kinetics, use the mnemonic **"WATT P"**: * **W**arfarin (at very high doses) * **A**lcohol (Ethanol) - *Most common example* * **T**heophylline * **T**olbutamide * **P**henytoin / **P**ropylthiouracil / **P**alicylates (Aspirin) **Key Distinction:** In zero-order kinetics, the **half-life ($t_{1/2}$) is not constant**; it increases as the administered dose increases.

Question 342: Regarding phenytoin, all are true except?

A. Potent microsomal enzyme inducer
B. Highly protein bound
C. At lower concentration, it follows zero-order kinetics (Correct Answer)
D. With increasing dose, the half-life increases

Explanation: ### Explanation The correct answer is **C**. This statement is false because Phenytoin follows **First-order kinetics at lower (therapeutic) concentrations** and shifts to **Zero-order kinetics at higher concentrations**. #### 1. Why Option C is the Correct Choice (The "Except") Phenytoin exhibits **Capacity-Limited Metabolism** (also known as Michaelis-Menten or Mixed-order kinetics). * **At low doses:** The metabolizing enzymes (CYP2C9/19) are not saturated. The rate of metabolism is proportional to the plasma concentration (**First-order kinetics**). * **At high doses:** The enzymes become saturated. The drug is then metabolized at a constant rate regardless of the concentration (**Zero-order kinetics**). Therefore, saying it follows zero-order at *lower* concentrations is factually incorrect. #### 2. Analysis of Other Options * **Option A (True):** Phenytoin is a **potent inducer** of Cytochrome P450 enzymes (CYP3A4, CYP2C9). It increases the metabolism of co-administered drugs like warfarin, oral contraceptives, and steroids. * **Option B (True):** It is **highly protein-bound (~90%)**, mainly to albumin. Conditions like hypoalbuminemia or uremia can increase the free (active) fraction of the drug, leading to toxicity even at "normal" total plasma levels. * **Option D (True):** Because it shifts to zero-order kinetics as dose increases, the elimination mechanisms become saturated. Consequently, the **half-life is not constant**; it increases significantly as the plasma concentration rises. #### 3. High-Yield Clinical Pearls for NEET-PG * **Therapeutic Window:** 10–20 µg/ml. Small dose increments above this range can lead to a disproportionate, non-linear rise in plasma levels (Toxicity). * **Teratogenicity:** Causes **Fetal Hydantoin Syndrome** (cleft lip/palate, digital hypoplasia). * **Specific Side Effects:** Gum hypertrophy (due to increased PDGF), Hirsutism, Osteomalacia (Vitamin D deficiency), and Megaloblastic anemia (Folate deficiency). * **Drug of Choice:** For Generalized Tonic-Clonic Seizures (GTCS) and Status Epilepticus (Fosphenytoin is preferred IV). It is **ineffective** in Absence Seizures.

Question 343: Metabolism of a drug primarily results in?

A. Activation of the active drug
B. Conversion of prodrug to active metabolite
C. Conversion of lipid-soluble drugs to water-soluble metabolites (Correct Answer)
D. Conversion of water-soluble drugs to lipid-soluble metabolites

Explanation: The primary objective of drug metabolism (biotransformation) is to facilitate the **excretion** of drugs from the body [1, 2]. Most drugs are lipid-soluble (lipophilic) to allow for easy absorption across cell membranes. However, the kidneys cannot efficiently excrete lipophilic substances because they undergo passive reabsorption in the renal tubules. Metabolism prevents accumulation of lipophilic drugs by converting them into more hydrophilic forms [2]. **1. Why Option C is Correct:** Metabolism (primarily in the liver via Phase I and Phase II reactions) converts **lipid-soluble** drugs into **water-soluble (polar/hydrophilic)** metabolites [2]. These polar metabolites are not reabsorbed by the renal tubules and are easily excreted in urine or bile [2]. This is the "general rule" of metabolism. **2. Why Other Options are Incorrect:** * **Option A:** While some drugs are metabolized into active metabolites (e.g., Diazepam to Oxazepam), the *primary* result for the majority of drugs is **inactivation** (detoxification) [1, 3]. * **Option B:** This describes the specific case of **Prodrugs** (e.g., Enalapril to Enalaprilat). While clinically important, it is an exception rather than the primary general result of metabolism [1, 3]. * **Option D:** This is physiologically counterproductive. Converting water-soluble drugs to lipid-soluble ones would lead to drug accumulation and toxicity, as they would be reabsorbed into the systemic circulation. **NEET-PG High-Yield Pearls:** * **Phase I Reactions:** Include Oxidation (most common), Reduction, and Hydrolysis. They introduce/mask a functional group [2, 3]. **Cytochrome P450** enzymes are the key players. * **Phase II Reactions:** Include Conjugation (Glucuronidation, Acetylation, Sulfation). These significantly increase water solubility [2]. **Glucuronidation** is the most common Phase II reaction. * **Exception to Inactivation:** Morphine-6-glucuronide is a rare example where a Phase II metabolite is *more* active than the parent drug. * **First-pass metabolism:** Drugs with high first-pass metabolism (e.g., Nitroglycerin, Lidocaine) have low oral bioavailability.

Question 344: Bioavailability is defined as:

A. The fraction of an administered dose of unchanged drug that reaches the systemic circulation (Correct Answer)
B. The extent of drug metabolism in the liver before reaching the systemic circulation
C. The extent of drug metabolism in the liver after reaching the systemic circulation
D. The fraction of a dose administered via the rectal route that reaches the systemic circulation

Explanation: ### Explanation **1. Why Option A is Correct:** Bioavailability ($F$) refers to the rate and extent to which the active ingredient or therapeutic moiety is absorbed from a drug product and becomes available at the site of drug action. For most drugs, this is measured as the fraction of the **unchanged drug** that reaches the **systemic circulation**. By definition, a drug administered **intravenously (IV)** has **100% bioavailability ($F=1$)**, as it bypasses absorption barriers and first-pass metabolism. **2. Why the Other Options are Incorrect:** * **Option B:** This describes the **First-pass effect (Pre-systemic metabolism)**. While high first-pass metabolism *reduces* bioavailability, it is not the definition of bioavailability itself. * **Option C:** Metabolism occurring *after* reaching systemic circulation is part of **drug clearance or elimination**, not bioavailability. * **Option D:** This is too narrow. While rectal administration has a specific bioavailability, the definition applies to **all routes** (oral, topical, etc.), not just rectal. **3. High-Yield Clinical Pearls for NEET-PG:** * **Calculation:** Bioavailability is calculated using the **Area Under the Curve (AUC)**. $F = \frac{AUC_{\text{oral}}}{AUC_{\text{IV}}} \times 100$ * **Bioequivalence:** Two pharmaceutical products are bioequivalent if their bioavailabilities (rate and extent of absorption) are not significantly different when administered at the same molar dose. * **Factors affecting Bioavailability:** First-pass metabolism (most common), drug solubility, chemical instability (e.g., penicillin in gastric acid), and the nature of the drug formulation. * **Pro-tip:** Drugs with low oral bioavailability (e.g., Nitroglycerin, Lidocaine) must be given via non-oral routes to achieve therapeutic levels.

Question 345: Which of the following best describes an essential drug?

A. Drugs that have been developed specifically to treat a rare medical condition.
B. Drugs that satisfy the healthcare needs of the majority of the population. (Correct Answer)
C. Drugs that satisfy the healthcare needs of at least 50% of the population.
D. Drugs to be used within the first hour of the acute attack of a disease.

Explanation: **Explanation:** The concept of **Essential Medicines**, as defined by the World Health Organization (WHO), refers to drugs that satisfy the **priority healthcare needs of the majority of the population**. These drugs are selected based on disease prevalence, evidence of efficacy and safety, and comparative cost-effectiveness. They are intended to be available within the context of functioning health systems at all times, in adequate amounts, in appropriate dosage forms, with assured quality, and at a price the individual and the community can afford. **Analysis of Options:** * **Option B (Correct):** This aligns with the WHO definition. Essential drugs focus on the "majority" to ensure the greatest public health impact. * **Option A (Incorrect):** This describes **Orphan Drugs**. These are used for the diagnosis, prevention, or treatment of rare diseases (e.g., Digoxin Immune Fab for digitalis toxicity). * **Option C (Incorrect):** The definition specifies the "majority" (which implies a priority for the bulk of the population's needs), not a specific mathematical threshold like 50%. * **Option D (Incorrect):** This refers to the concept of the **"Golden Hour"** in emergency medicine or specific emergency medications, not the administrative classification of essential drugs. **NEET-PG High-Yield Pearls:** * **WHO Model List:** First published in 1977; updated every 2 years. * **National List of Essential Medicines (NLEM):** India’s version of the list, which forms the basis for price control by the NPPA (National Pharmaceutical Pricing Authority). * **Selection Criteria:** Public health relevance, proven efficacy/safety, and cost-effectiveness (not just the cheapest drug). * **P-Drugs (Personal Drugs):** Do not confuse Essential Drugs with P-drugs. P-drugs are those a physician chooses to prescribe regularly for a specific condition based on their own practice and preference.

Question 346: Which of the following drugs does NOT have high hepatic clearance?

A. Labetalol
B. Simvastatin
C. Morphine
D. Paracetamol (Correct Answer)

Explanation: ### Explanation The concept of **Hepatic Clearance** depends on the **Extraction Ratio (ER)**. Drugs with a high ER (>0.7) are cleared rapidly by the liver, meaning their clearance is limited by hepatic blood flow (Flow-dependent clearance). Drugs with a low ER (<0.3) are cleared slowly, and their clearance depends on the metabolic capacity of enzymes (Capacity-limited clearance). **1. Why Paracetamol is the correct answer:** Paracetamol has a **low hepatic extraction ratio**. While it is primarily metabolized by the liver (glucuronidation and sulfation), the process is relatively slow compared to hepatic blood flow. Therefore, it does not undergo extensive first-pass metabolism to the same degree as high-ER drugs, and its systemic bioavailability is high (approx. 70-90%). **2. Why the other options are incorrect:** * **Labetalol:** This is a classic example of a drug with a **high extraction ratio**. It undergoes significant first-pass metabolism, leading to lower oral bioavailability. * **Simvastatin:** This is a prodrug with very high hepatic extraction. It is specifically taken up by the liver (its target organ) during the first pass, resulting in less than 5% systemic bioavailability. * **Morphine:** Morphine undergoes extensive first-pass metabolism (primarily glucuronidation), giving it a high hepatic clearance. This is why the oral dose of morphine must be significantly higher than the parenteral dose to achieve the same effect. **Clinical Pearls for NEET-PG:** * **High ER Drugs (Mnemonic: "LIVS"):** **L**idocaine, **I**sosorbide dinitrate, **V**erapamil, **S**albutamol. Also includes Propranolol, Nitroglycerin, and Pethidine. * **Flow-dependent clearance:** For high ER drugs, any condition that decreases hepatic blood flow (e.g., Congestive Heart Failure, Propranolol) will decrease their clearance. * **Bioavailability:** Drugs with high hepatic clearance always have low oral bioavailability.

Question 347: Metabolism of xenobiotics is carried out by which of the following?

A. Cytochrome
B. Cytochrome P450 (Correct Answer)
C. Cytochrome C
D. Cytochrome A

Explanation: **Explanation:** **Why Cytochrome P450 is Correct:** Xenobiotics (foreign substances like drugs, toxins, and pollutants) undergo biotransformation primarily in the liver to become more water-soluble for excretion [1, 3]. This process is divided into Phase I (Nonsynthetic) and Phase II (Synthetic) reactions [1, 3]. **Cytochrome P450 (CYP450)** enzymes are a superfamily of heme-containing proteins located in the smooth endoplasmic reticulum (microsomes) that catalyze **Phase I reactions**, specifically oxidative metabolism [1]. They are the most critical enzymes for drug metabolism in humans. **Analysis of Incorrect Options:** * **Cytochrome (Option A):** This is a general term for a large group of hemoproteins. While CYP450 is a type of cytochrome, "Cytochrome" alone is too non-specific. * **Cytochrome C (Option C):** This is a component of the **electron transport chain (ETC)** located in the inner mitochondrial membrane. Its primary role is cellular respiration (ATP production) and initiating apoptosis, not drug metabolism. * **Cytochrome A (Option D):** This is part of the Cytochrome c oxidase complex (Complex IV) in the mitochondrial ETC, involved in transferring electrons to oxygen. **High-Yield Clinical Pearls for NEET-PG:** 1. **CYP3A4:** The most abundant CYP isoenzyme in the liver; it metabolizes approximately 50% of all clinically used drugs. 2. **Inducers vs. Inhibitors:** * *Inducers* (e.g., Rifampicin, Phenytoin, Carbamazepine) decrease the plasma concentration of co-administered drugs. * *Inhibitors* (e.g., Ketoconazole, Erythromycin, Grapefruit juice) increase drug toxicity. 3. **Polymorphism:** CYP2D6 exhibits significant genetic polymorphism, affecting the metabolism of drugs like codeine and metoprolol (Poor vs. Ultra-rapid metabolizers).

Question 348: The mechanism of action of protamine, an antidote for heparin, is based on which of the following?

A. Competitive antagonism
B. Chemical antagonism (Correct Answer)
C. Non-competitive antagonism
D. Toxic reaction

Explanation: **Explanation:** **1. Why Chemical Antagonism is Correct:** Chemical antagonism occurs when two substances combine in solution, resulting in the chemical neutralization of the drug's effect without involving a specific biological receptor. **Heparin** is a highly acidic, negatively charged molecule (polyanion). **Protamine sulfate** is a strongly basic, positively charged protein (polycation). When administered, protamine binds ionically to heparin to form a stable, inactive **salt complex**. This direct chemical interaction neutralizes heparin’s anticoagulant activity, making it a classic example of chemical antagonism. **2. Why Other Options are Incorrect:** * **A. Competitive Antagonism:** This involves two drugs competing for the same receptor site (e.g., Atropine vs. Acetylcholine at muscarinic receptors). Protamine does not bind to the antithrombin III receptor site; it binds to the drug itself. * **C. Non-competitive Antagonism:** This occurs when an antagonist binds to an allosteric site or irreversibly to the receptor, preventing the agonist from producing a maximal effect. Again, this requires a receptor-mediated mechanism, which is absent here. * **D. Toxic Reaction:** While protamine can have side effects (like hypotension or anaphylaxis), its primary therapeutic mechanism is neutralization, not toxicity. **3. NEET-PG High-Yield Clinical Pearls:** * **Dosage:** 1 mg of protamine neutralizes approximately 100 units of heparin. * **Source:** Protamine is derived from **salmon sperm**; patients with fish allergies or those who have had vasectomies (due to anti-sperm antibodies) are at higher risk of hypersensitivity. * **Paradoxical Effect:** Excessive doses of protamine can actually exert an anticoagulant effect by inhibiting platelets and clotting factors. * **Other Examples of Chemical Antagonism:** Chelating agents (like Dimercaprol for heavy metals) and antacids neutralizing gastric acid.

Question 349: All of the following are microsomal enzyme inhibitors except?

A. Glucocorticoids (Correct Answer)
B. Cimetidine
C. Ciprofloxacin
D. Isoniazid

Explanation: **Explanation:** The correct answer is **Glucocorticoids** because they are **microsomal enzyme inducers**, not inhibitors. **1. Why Glucocorticoids are the correct answer:** Microsomal enzymes (primarily Cytochrome P450 enzymes in the liver) are responsible for the metabolism of various drugs. **Enzyme Inducers** increase the synthesis of these enzymes, leading to faster metabolism and decreased plasma levels of co-administered drugs. Glucocorticoids (like Dexamethasone) act as inducers, whereas the question asks for the "exception" among inhibitors. **2. Analysis of Incorrect Options (Enzyme Inhibitors):** * **Cimetidine:** A classic, potent H2-receptor antagonist known for inhibiting multiple CYP isoforms (CYP1A2, 2C9, 2D6, 3A4). It frequently causes drug interactions (e.g., increasing Warfarin or Theophylline levels). * **Ciprofloxacin:** A Fluoroquinolone that specifically inhibits **CYP1A2**, which can lead to toxicity of drugs like Theophylline. * **Isoniazid (INH):** A primary anti-tubercular drug that inhibits microsomal enzymes, notably increasing the levels of Phenytoin and Carbamazepine. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** To remember these for the exam, use these popular mnemonics: * **Enzyme Inhibitors (VITAMIN K):** **V**alproate, **I**soniazid, **T**ame (Cimetidine), **A**miodarone, **M**acrolides (except Azithromycin), **I**ndinavir, **N**eferodone, **K**etoconazole (and other Azoles), plus **Ciprofloxacin** and **Grapefruit juice**. * **Enzyme Inducers (GPRS Cell Phone):** **G**riseofulvin, **P**henytoin, **R**ifampicin, **S**moking, **C**arbamazepine, **P**henobarbitone. Note: **Glucocorticoids** and **Chronic Alcoholism** also fall into this category. **Key Concept:** Inhibition is usually rapid (starts within 24 hours), whereas Induction is a slower process as it requires new protein synthesis.

Question 350: Which of the following is NOT an example of a Phase II drug metabolic reaction?

A. Acetylation
B. Sulfation
C. Decyclization (Correct Answer)
D. Methylation

Explanation: Drug metabolism (biotransformation) occurs in two distinct phases to make lipophilic drugs more water-soluble for excretion. **Explanation of the Correct Answer:** **Decyclization** is a **Phase I reaction**. Phase I reactions (Nonsynthetic) involve the introduction or unmasking of a functional group through oxidation, reduction, or hydrolysis. Decyclization specifically refers to the opening of a ring structure (e.g., the metabolism of barbiturates). Other Phase I reactions include Oxidation (most common, via CYP450), Reduction, Hydrolysis, and Cyclization. **Explanation of Incorrect Options:** Phase II reactions (Synthetic/Conjugation) involve attaching an endogenous moiety to the drug to form a highly polar, inactive metabolite. * **A. Acetylation:** A Phase II reaction catalyzed by N-acetyltransferase (NAT). Common examples include Sulfonamides, Isoniazid, and Hydralazine. * **B. Sulfation:** A Phase II reaction where a sulfate group is added (e.g., for Paracetamol or Steroids). * **D. Methylation:** A Phase II reaction involving the addition of a methyl group (e.g., for Adrenaline or Histamine). **High-Yield NEET-PG Pearls:** * **Glucuronidation** is the most common Phase II reaction. * **Microsomal vs. Non-microsomal:** Most Phase I and Glucuronidation enzymes are microsomal (located in the SER). Other Phase II reactions (Acetylation, Sulfation) are primarily **non-microsomal (cytosolic)**. * **Pharmacogenetics:** Acetylation shows genetic polymorphism (Fast vs. Slow acetylators), which is clinically significant for drugs like Isoniazid (risk of peripheral neuropathy in slow acetylators). * **Exception:** While Phase II usually inactivates drugs, **Morphine-6-glucuronide** is a rare example of a Phase II metabolite that is more active than the parent drug.

Practice by Chapter

Absorption and Bioavailability

Practice Questions

Drug Distribution and Protein Binding

Practice Questions

Biotransformation and Metabolism Pathways

Practice Questions

Renal and Non-renal Excretion

Practice Questions

Compartment Models

Practice Questions

Dose-Response Relationships

Practice Questions

Drug Efficacy and Potency

Practice Questions

Drug Tolerance and Tachyphylaxis

Practice Questions

Population Pharmacokinetics

Practice Questions

Pharmacokinetic Variability

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free